BioInvent Completes First Licensing Agreement in Greater China...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEW YORK, Oct. 29, 2020 /PRNewswire-AsiaNet/ -- M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 i...
Authors: LATEST ASIANET NEWS RELEASES